Bullish Case: ASTS has substantial cash, 13 satellites in orbit, 10 launches booked, 60+ operator relationships, and a reaffirmed 45-satellite/early-2027 target. Q2 revenue reached $31.5M despite a miss, while government awards and consumer-beta plans provide identifiable catalysts. Calls traded 35% more volume than puts. Helium’s price-density peak near $70–72 and lower modeled IV than market imply room for a favorable surprise if launch and throughput evidence arrives.

Bearish Case: Execution remains the valuation bottleneck: Q2’s $230.9M loss widened sharply, revenue missed estimates, cash burn persists, and the $1B convertible creates dilution near the $79.57 conversion price. Near-dated puts remain actively traded and ASTS IV is extreme versus SPY. Market term IV stays 81.5–88.7%, while the historical surface permits severe tails. Delayed launches, weak throughput, or beta slippage could overwhelm partnership optimism.

Potential Outcomes:

1. 35% — Range-bound $65–80 through September; oracle: no validated throughput or beta date, with IV staying elevated.
2. 30% — Catalyst rally to $82–100; oracle: successful launch/service evidence and call IV compression.
3. 20% — Execution or financing disappointment, $50–65; oracle: launch slip, weak telemetry, or dilution below market.
4. 15% — Broad risk-off, $45–60; SPY surface remains calm today, so this is a tail scenario.

Prior bullish calls over-weighted catalyst timing and IV compression; bearish execution warnings proved more reliable. Helium’s forecast is neutral, its density peaks near $70–72, and bearish risk exceeds bullish risk by 1%.

August 18, 2026